Taxane‐containing chemotherapy leads to lower overall survival compared with any chemotherapy without taxane (high certainty).
The review found no eligible studies for this question.
Summary of findings: Non‐intensive showed no clear difference in overall survival compared with intensive follow‐up (high certainty).
Summary of findings: Decentralised showed no clear difference in overall survival compared with centralised follow‐up (moderate certainty).
Taxane followed by anthracyclines showed no clear difference in overall survival ( compared with anthracyclines followed by taxane (moderate certainty).
The intervention leads to lower overall survival (OS) (high certainty).
High‐dose chemotherapy showed no clear difference in overall survival at 5‐year compared with chemotherapy without bone marrow transplant or stem cell rescue (high certainty).
OFS leads to lower overall survival (OS) Median compared with no OFS (high certainty).
Bisphosphonates leads to lower overall survival compared with placebo/observation (high certainty).
Summary of Findings Table ‐ PBI?APBI showed no clear difference in overall survival compared with WBRT (high certainty).
Capecitabine‐containing regimens probably leads to lower overall survival (OS)median compared with non‐capecitabine‐containing regimens or no chemotherapy (moderate certainty).
Summary of findings table ‐ Postmastectomy radiotherapy (PMRT) probably leads to lower overall survival (OS) compared with no PMRT (moderate certainty).
Bisphosphonates leads to lower overall survival postmenopausal women compared with placebo/observation (high certainty).
Bisphosphonates showed no clear difference in overall survival: pre‐ or perimenopausal women compared with placebo/observation (high certainty).